Effects of novel therapies new insights into old medicationsImproved understanding of the interactions between 2GPI, aPL Abs and cell-surface molecules such as annexins has led to the development of a potential therapy by blocking binding of anti-2GPI Abs to 2GPI. Ioannou et al. were able to demonstrate the use of a recombinant domain I peptide, which effectively inhibits binding of anti-2GPI Ab
64188 Web Directory
64188.org web directory is committed to maintain high standard of listings to ensure the success of the listed sites.
![](https://craftaid.net/img/iconicwebz.png)
![](https://craftaid.net/img/hostperl.jpeg)
![](https://craftaid.net/img/onyxrack.png)
![](https://craftaid.net/img/hostperl.jpeg)
![](https://craftaid.net/img/hostperlca.png)
Latest Comments
Log in to comment or register here.